Lord (Paul) Drayson. Pic: Sensyne Health

Sensyne Health’s latest research deal with NHS Foundation Trust brings total patient dataset to more than five million

 1 min | By Gill Oliver
 | Pharma | Healthcare | Biotech | Medical | AI | Nov 17th 2020

Clinical AI company Sensyne Health has signed a five-year strategic research agreement with Somerset NHS Foundation Trust.

The dataset covers just over one million unique patient records, with all data anonymised by Somerset beforehand.

go deeper
Sensyne already has arrangements in place with Oxford University Hospitals NHS Foundation Trust, Chelsea & Westminster Hospitals NHS Foundation Trust, South Warwickshire NHS Foundation Trust, Wye Valley NHS Trust, George Eliot NHS Trust, Milton Keynes University Hospital NHS Foundation Trust and NHS Greater Glasgow and Clyde.

This brings AIM-listed Sensyne’s total anonymised patient data available for analysis to 5.6 million patients.

Sensyne Health chief executive Lord (Paul) Drayson says: “This new agreement will enable research to improve patient care and accelerate medical research and by helping to grow our overall data set to over 5.6m patients, will now enable us to broaden our research and expand our therapeutic focus.”

About the Author

Gill Oliver

Gill Oliver is a professionally trained journalist who’s written for The New Statesman, The Bureau for Investigative Journalism, The Daily Mail’s business section This is Money, The Press Association, The Huffington Post plus a host of national magazines, news agencies and trade and industry journals. She’s also spent nine years reporting on the Oxfordshire business and tech scene for The Oxford Times and The Oxford Mail.

Subscribe to our newsletter